Abstract:Highlights • Rare ginsenosides (RGs), as the shining components, possessed great potential in drugs and nutraceuticals. • A total of 144 rare ginsenosides with diverse skeletons and bioactivities were isolated from Panax species. • RGs showed superior bioactivity for cardiovascular disease and cancer, in addition, they acted as natural ligands for some specific receptors. • The stereochemistry properties of RGs brought out diverse bioactivities, together with novel analytical strategies of phytochemistry. • Physico-chemical transformation, biotransformation, and biosynthesis are now serving as promising methods for RGs production. Background Rare ginsenosides (Rg3, Rh2, C-K, etc .) refer to a group of dammarane triterpenoids that exist in low natural abundance, mostly produced by deglycosylation or side chain modification via physicochemical processing or metabolic transformation in gut, and last but not least, exhibited potent biological activity comparing to the primary ginsenosides, which lead to a high concern in both the research and development of ginseng and ginsenoside-related nutraceutical and natural products. Nevertheless, a comprehensive review on these promising compounds is not available yet. Aim of Review In this review, recent advances of Rare ginsenosides (RGs) were summarized dealing with the structurally diverse characteristics, traditional usage, drug discovery situation, clinical application, pharmacological effects and the underlying mechanisms, structure-activity relationship, toxicity, the stereochemistry properties, and production strategies. Key Scientific Concepts of Review A total of 144 RGs with diverse skeletons and bioactivities were isolated from Panax species. RGs acted as natural ligands on some specific receptors, such as bile acid receptors, steroid hormone receptors, and adenosine diphosphate (ADP) receptors. The RGs showed promising bioactivities including immunoregulatory and adaptogen-like effect, anti-aging effect, anti-tumor effect, as well as their effects on cardiovascular and cerebrovascular system, central nervous system, obesity and diabetes, and interaction with gut microbiota. Clinal trials indicated the potential of RGs, while high quality data remains inadequate, and no obvious side effects was founded. The stereochemistry properties induced by deglycosylation at C (20) were also addressed including pharmacodynamics behaviors, together with the state-of-art analytical strategies for the identification of saponin stereoisomers. Finally, the batch preparation of targeted RGs by designated strategies including heating or acid/ alkaline-assisted processes, and enzymatic biotransformation and biosynthesis were discussed. Hopefully, the present review can provide more clues for the extensive understanding and future in-depth research and development of RGs, originated from the worldwide well recognized ginseng plants. Graphical abstract Download : Download high-res image (138KB) Download : Download full-size image

Biopharmaceutical Characters and Bioavailability Improving Strategies of Ginsenosides

STUDY ON METABONOMICS MECHANISM OF COMPATIBILITY OF GINSENOSIDES AND TENUIGENINS ON ALZHEIMER’S DISEASE RATS BASED ON UPLC-MS

Methods on Improvements of the Poor Oral Bioavailability of Ginsenosides: Pre-processing, Structural Modification, Drug Combination, and Micro- or Nano- Delivery System

Strategic Enrichment of Ocotillol-Type Ginsenosides F11, RT5 and Ocotillol from Panax Quinquefolium

Insight on structural modification, biological activity, structure-activity relationship of PPD-type ginsenoside derivatives.

Pharmacology of ginsenosides: a literature review

Biocatalytic strategies in producing ginsenoside by glycosidase-a review

Recent advances in nano and micro formulations of Ginsenoside to enhance their therapeutic efficacy

Recent Advances in the Semisynthesis, Modifications and Biological Activities of Ocotillol-Type Triterpenoids

Recent advances in systemic and local delivery of ginsenosides using nanoparticles and nanofibers

Molecular Mechanisms Governing Different Pharmacokinetics of Ginsenosides and Potential for Ginsenoside-Perpetrated Herb-Drug Interactions on Oatp1b3

Preparation and bioactivity of the rare ginsenosides Rg3 and Rh2: An updated review

Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies

A strategy for efficient discovery of new natural compounds by integrating orthogonal column chromatography and liquid chromatography/mass spectrometry analysis: Its application in Panax ginseng, Panax quinquefolium and Panax notoginseng to characterize 437 potential new ginsenosides.

Pharmacokinetic Studies of Chemical Constituents of Ginseng

Influence of Glycerol/Dimethylsulfoxide Homogeneous Solution on PNS Bioavailability in rats

Characterization of Pharmacokinetic Profiles and Metabolic Pathways of 20(S)-Ginsenoside Rh1 in Vivo and in Vitro

Synthesis of Ocotillol-Type Ginsenosides.

Advances in study of ginsenoside biosynthesis pathway in Panax ginseng C. A. Meyer

Rare ginsenosides: a unique perspective of ginseng research

Advancements in Enzymatic Biotransformation and Bioactivities of Rare Ginsenosides：a Review